Lazard Asset Management
THTX

Lazard Asset Management’s Theratechnologies THTX Stock Holding History

Lazard Asset Management’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,838
Closed -$27K – 2307
2025
Q2 		$27K Buy
11,838
+11,348
+2,316% +$27.8K ﹤0.01% 2100
2025
Q1 		$0 Buy
+490
New +$818 ﹤0.01% 2576

Other funds holding THTX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIP
Greatmark Investment Partners Columbus, Georgia $854M AUM 15.72% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM

Lazard Asset Management's THTX Position: Q3 2025 in Review

Lazard Asset Management sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 11,838 shares — an estimated $27K sold.

Lazard Asset Management first reported a position in THTX in Q1 2025 and held it in 2 quarters. The position peaked at $27K in Q2 2025. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • Lazard Asset Management reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 11,838 Theratechnologies shares in Q3 2025, an estimated $27K.
  • Lazard Asset Management first reported a position in Theratechnologies in Q1 2025 and held it in 2 quarters.
  • Lazard Asset Management's Theratechnologies position peaked at $27K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.